Structural and functional consequences of buserelin-induced enteric neuropathy in rat [Elektronisk resurs]

Sand, Elin (författare)

Roth, Bodil (författare)

Weström, Björn (författare)

Bonn, Peter (författare)

Ekblad, Eva (författare)

Ohlsson, Bodil (författare)

Lunds universitet (utgivare)

Alternativt namn: Universitetet i Lund

Alternativt namn: Engelska: Lund University

Alternativt namn: Engelska: University of Lund

Alternativt namn: Tyska: Universität Lund

Alternativt namn: Latin: Universitas Gothorum Carolina

Alternativt namn: Latin: Universitas Regia Lundensis

Se även: Lunds tekniska högskola

Lund BMC Biomedical Centre, Lund University 2016-04-01T00:00:00+02:00
Engelska.

Läs hela texten

E-bok

Sammanfattning

Stäng

Background: Women treated with gonadotropin-releasing hormone (GnRH) analogs may develop enteric neuropathy and dysmotility. Administration of a GnRH analog to rats leads to similar degenerative neuropathy and ganglioneuritis. The aim of this study on rat was to evaluate the early GnRH-induced enteric neuropathy in terms of distribution of neuronal subpopulations and gastrointestinal (GI) function. Methods: Forty rats were given the GnRH analog buserelin (20 mu g, 1 mg/ml) or saline subcutaneously, once daily for 5 days, followed by 3 weeks of recovery, representing one treatment session. Two weeks after the fourth treatment session, the animals were tested for GI transit time and galactose absorption, and fecal weight and fat content was analyzed. After sacrifice, enteric neuronal subpopulations were analyzed. Blood samples were analyzed for zonulin and antibodies against GnRH and luteinizing hormone, and their receptors. Results: Buserelin treatment transiently increased the body weight after 5 and 9 weeks (p < 0.001). Increased estradiol in plasma and thickened uterine muscle layers indicate high estrogen activity. The numbers of both submucous and myenteric neurons were reduced by 27%? 61% in ileum and colon. The relative numbers of neurons containing calcitonin gene-related peptide (CGRP), cocaine-and amphetamine-related transcript (CART), galanin, gastrin-releasing peptide (GRP), neuropeptide Y (NPY), nitric oxide synthase (NOS), serotonin, substance P (SP), vasoactive intestinal peptide (VIP) or vesicular acetylcholine transporter (VAchT), and their nerve fiber density, were unchanged after buserelin treatment, but the relative number of submucous neurons containing somatostatin tended to be increased (p = 0.062). The feces weight decreased in buserelin-treated rats (p < 0.01), whereas feces fat content increased (p < 0.05), compared to control rats. Total GI transit time, galactose absorption, zonulin levels in plasma, and antibody titers in serum were unaffected by buserelin treatment. Conclusions: A marked enteric neuronal loss with modest effects on GI function is found after buserelin treatment. Increased feces fat content is suggested an early sign of dysfunction.

Länka till posten

Inställningar Hjälp

Uppgift om bibliotek saknas i LIBRIS

Kontakta ditt bibliotek, eller sök utanför LIBRIS. Se högermenyn.

1 av 1
Föregående post
Nästa post
Till träfflistan

Sök vidare

Hjälp

Fler titlar av: Sand, Elin; Roth, Bodil; Weström, Björn; Bonn, Peter; Ekblad, Eva; Ohlsson, Bodil; visa fler...; Lunds universitet; visa färre...

Sök utanför LIBRIS

Hjälp

Sök vidare i:: Google; Google Book Search; Google Scholar; LibraryThing

Om LIBRIS: Sekretess

Hjälp: Fel i posten?; Kontakt; Teknik och format

Sök utifrån: Sökrutor; Plug-ins; Bookmarklet

Anpassa: Textstorlek; Kontrast; Vyer

LIBRIS söktjänster: SwePub; Uppsök

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.